2 matches for your search in the start-up spotlight
rss
matching the following criteria
Sort by:
Elthera AG
Elthera AG is developing antibodies against the novel target L1CAM, an adhesion molecule whose expression is strongly correlated with an aggressive tumor phenotype and poor prognosis in various types of cancer. Inhibition of L1CAM targets many mechanisms of tumor progression such as resistance to ...
